ACC Working Group

Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy

Period in office: 2019-2025

see above under Secretary

NAPACA Working Group

Cristina Ronchi MD, PhD, FRCP, DSc

Institute of Metabolism and Systems Research (IMSR)

University of Birmingham

& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)

Birmingham Health Partners

Birmingham, UK

& Department of Endocrinology and Diabetes

University Hospital of Wuerzburg

Wuerzburg (Germany)

Dr Cristina L Ronchi is Reader in Endocrine Oncology at the Institute of Metabolism and Systems Research (University of Birmingham, UK). She is also Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her current research field focuses on the molecular pathogenesis of adrenocortical tumours and Cushing syndrome as well as novel prognostic markers for patients with adrenocortical cancer.

Dr Ronchi is a member of many national and international societies, is on the editorial board of several international journals and coordinated multiple studies on behalf of the ENS@T. 

APA Working Group

Marcus Quinkler, MD

Berlin, Germany

Marcus Quinkler is Professor of Internal Medicine and Endocrinology and consultant in the endocrine outpatient center “Endocrinology in Charlottenburg” in Berlin, Germany.

His clinical research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, and mineralocorticoid and glucocorticoid action.

Chairs of local ENSAT scientific meetings committees

Darko Kastelan, 22nd ENS@T meeting 2023, Dubrovnik, Croatia. Period in office: 2021-2023

---------------------------------------------------------------------------------------------------------------------------------------------

Martin Fassnacht, MD
 Head of the Division of Endocrinology and Diabetes
 Department of Internal Medicine I
 University Hospital Würzburg
 Oberdürrbacherstr. 6
 Würzburg, Germany

Martin Fassnacht is Professor of Internal Medicine and Endocrinology at the University of Würzburg. He is head of the Division of Endocrinology and Diabetes at the University Hospital Würzburg. The main interest of his clinical and translational research group is endocrine tumors with a special focus on adrenal tumors. He run(s) several clinical trials for patients with adrenocortical carcinoma and malignant pheochromocytoma and his translational group is adrenocortical tumorigenesis and drug targets for adrenocortical carcinoma.

Period in office as president: 2016-2021

Period in office as ordinary member: 2021-2022

Henri Timmers, MD, PhD
 Division of Endocrinology
 Department of Internal Medicine
 Radboud University Medical Centre
 Geert Grooteplein Zuid 8
 Radboud, The Netherlands

Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international  Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.

Period in office as secretary: 2019-2022

Martin Reincke, MD

Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Martin Heinrich Reincke is the director of the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich and Chair of the Department of Endocrinology and Diabetology..

His research focus includes adrenal physiology and pathophysiology, endocrine hypertension, pituitary disease, mineralocorticoid and glucocorticoid action and stress research. Professor Reincke is heading a research team specifically exploring the prevalence and relevance of mineralocorticoid excess in resistant hypertension on the epidemiological, clinical, genetic and molecular level.

Professor Reincke is a member of many national and international societies, including the Endocrine Society, European Society of Endocrinology and European Network of the study of adrenal tumors. He has served in the Executive Board of the German Endocrine Society and European Society of Endocrinology, is on the editorial board of several international journals, and has served as teaching dean of the faculty from 2006-2012.

Period in office as Head of APA WG: 2017-2021

Wiebke Arlt, MD, DSc., FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR)
University of Birmingham
& Centre for Endocrinology, Diabetes and Metabolism (CEDAM)
Birmingham Health Partners
Birmingham, UK

Professor Wiebke Arlt is William Withering Chair of Medicine and Director of the Institute of Metabolism and Systems Research at the University of Birmingham, UK. She leads a multi-disciplinary research group focussing on steroid endocrinology in the context of adrenal and gonadal disorders. She is a Consultant Endocrinologist at the Queen Elizabeth Hospital Birmingham, where she serves as the Lead of the Adrenal Tumour Specialist Service. Her main interests are adrenal incidentaloma, adrenocortical carcinoma and adrenal steroid excess syndromes.

Period in office as Head of NAPACA WG: 2017-2021

Mercedes Robledo, PhD
Hereditary Endocrine Cancer, Group Leader
Human Cancer Genetics Programme
Spanish National Cancer Centre (CNIO)
C/ Melchor Fernández Almagro 3
Madrid, Spain

Mercedes Robledo is the head of the Hereditary Endocrine Cancer Group, in the Human Genetics Cancer Program at the Spanish National Cancer Center (CNIO), Madrid, Spain. Her Group is interested in identifying high and low genetic risk factors involved in pheochromocytoma and thyroid cancer susceptibility. To this end, we analyse tumour samples and look for differences between genomic features according to the different individual genetic backgrounds. Such comprehensive characterisation allows us, not only to define diagnostic and prognostic markers associated with primary mutations, but also to pinpoint specific altered pathways that can lead to the identification of future therapeutic targets.

Period in office as Head of PPGL WG: 2017-2021

Endocrine Research Unit
Medizinische Klinik und Poliklinik IV
University Hospital Munich
Ziemssenstr. 1
Munich, Germany

Felix Beuschlein is Professor of Internal Medicine/Endocrinology, Head of the Endocrine Research Unit and runs the Endocrine Outpatient Clinic at the University Hospital in Munich. His main scientific interest pertain to all fields of adrenal research including adrenocortical carcinoma, primary aldosteronism, Cushing’s syndrome and pheochromocytoma. He has served as the chairman of ENSAT between 2008 and 2016 and has led an FP7 funded consortium on adrenal tumors (ENSAT-CANCER).

Anne-Paule Gimenez-Roqueplo, MD, PhD
INSERM UMR 970
or/ Service de Génétique
Hôpital européen Georges Pompidou
rue Leblanc
Paris, France

Professor Anne-Paule Gimenez-Roqueplo (MD, specialized in Endocrinology, PhD in Genetics) is Full Professor in Genetics at Paris Descartes University. She is responsible of the Oncogenetic activity (molecular tests and multidisciplinary counsultation) in the Genetics department of Hôpital Européen Georges Pompidou (Paris, France). Her main interests are benign and malignant pheochromocytomas and paragangliomas (PPGL). She is the Director of an academic research team entitled “Pheochromocytomas and Paragangliomas, from Genetics to Molecular Targeted Therapies” within the INSERM Unit 970 at the Paris Cardiovascular Center at HEGP (PARCC@HEGP), Paris, France (http://parcc.inserm.fr/). She is the coordinator of PGL.R, the National French registry for SDHx-related paragangliomas.

Period in office as treasurer: 2013-2019

Tracy Ann Williams, BSc, PhD
Division of Internal Medicine and Hypertension
Department of Medical Sciences
University of Torino
Via Giuseppe Verdi 8
Torino, Italy

Dr. Williams heads the laboratory of genetics and molecular biology of hypertension in the Division of Internal Medicine and Hypertension, Department of Medical Sciences, University of Torino, Italy. She is visiting research scientist at the Medizinische Klinik and Poliklinik IV, Ludwig-Maximilians University in Munich. Her main interests are monogenic forms of hypertension and disorders of aldosterone production centering on aldosterone-producing adenomas.

Period in office as secretary: 2018-2019

Giuseppe Opocher, MD
Familial Cancer Clinic and Oncoendocrinology
Veneto Institute of Oncology
University of Padova
Via Gattamelata 64
Padova, Veneto, Italy

Period in office: 2014-2018

Henri Timmers, MD, PhD
 Division of Endocrinology
 Department of Internal Medicine
 Radboud University Medical Centre
 Geert Grooteplein Zuid 8
 Radboud, The Netherlands

Henri Timmers (1971), M.D./Ph.D., is clinical endocrinologist and assistant professor at the Department of Medicine, section of Endocrinology, Radboud University Medical Centre, in Nijmegen, the Netherlands. He is head of the Radboud Adrenal Center and member of the steering committees of ENS@T and the international  Pheochromocytoma and Paraganglioma Research Support Organization (PRESSOR). His principle clinical and scientific focus is on adrenal diseases, especially pheochromocytoma and paraganglioma.

Former Secretary of ENS@T. Period in office: 2011-2017

Jérôme Bertherat, MD, PhD
Institut National de la Santé et de la Recherche Médicale (INSERM)
Centre National de la Recherche Scientifique (CNRS)
Institut Cochin, Université Paris-Descartes
22, rue Mechain
Paris, France

Period in office: 2009-2016

Wiebke Arlt, Birmingham, UK. Period in office: 2009-2016

Massimo Terzolo, MD
Head of Department of Internal Medicine I
University of Torino
Regione Gonzole 10
Torino, Italy

Period in office: 2009-2014

Massimo Mannelli, Florence, Italy. Period in office: 2009-2011